BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2565088)

  • 1. Inhibitory regulation of rat exocrine pancreas by peptide YY and pancreatic polypeptide.
    Putnam WS; Liddle RA; Williams JA
    Am J Physiol; 1989 Apr; 256(4 Pt 1):G698-703. PubMed ID: 2565088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of pancreatic polypeptide and peptide YY on pancreatic blood flow and pancreatic exocrine secretion in the anesthetized dog.
    DeMar AR; Lake R; Fink AS
    Pancreas; 1991 Jan; 6(1):9-14. PubMed ID: 1994383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of calcitonin gene-related peptide in inhibiting pancreatic enzyme secretion in rats.
    Li Y; Kolligs F; Owyang C
    Gastroenterology; 1993 Jul; 105(1):194-201. PubMed ID: 8099887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide YY inhibits pancreatic secretion via cholinergic pathways.
    Brodish RJ; Kuvshinoff BW; Fink AS; McFadden DW
    J Surg Res; 1993 Jul; 55(1):103-8. PubMed ID: 8105149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PYY potently inhibits pancreatic exocrine secretion mediated through CCK-secretin-stimulated pathways but not 2-DG-stimulated pathways in awake rats.
    Deng X; Guarita DR; Wood PG; Kriess C; Whitcomb DC
    Dig Dis Sci; 2001 Jan; 46(1):156-65. PubMed ID: 11270780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of pancreastatin on pancreatic exocrine secretions. Pancreastatin inhibits central vagal nerve stimulation.
    Miyasaka K; Funakoshi A; Kitani K; Tamamura H; Funakoshi S; Fujii N
    Gastroenterology; 1990 Dec; 99(6):1751-6. PubMed ID: 1977653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Action of pancreatic polypeptide on rat pancreatic secretion: in vivo and in vitro.
    Louie DS; Williams JA; Owyang C
    Am J Physiol; 1985 Oct; 249(4 Pt 1):G489-95. PubMed ID: 2413769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic polypeptide microinjection into the dorsal motor nucleus inhibits pancreatic secretion in rats.
    Okumura T; Pappas TN; Taylor IL
    Gastroenterology; 1995 May; 108(5):1517-25. PubMed ID: 7729645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide YY inhibits nutrient-, hormonal-, and vagally-stimulated pancreatic exocrine secretion.
    Lluis F; Gomez G; Fujimura M; Greeley GH; Thompson JC
    Pancreas; 1987; 2(4):454-62. PubMed ID: 3628240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vagal efferent nerve-dependent inhibitory action of pancreatic polypeptide and peptide YY in conscious rats: comparison with somatostatin.
    Masuda M; Tomita H; Okubo K; Miyasaka K
    J Auton Nerv Syst; 1994 Dec; 50(2):131-8. PubMed ID: 7884153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic polypeptide and peptide YY inhibit the denervated canine pancreas.
    DeMar AR; Taylor IL; Fink AS
    Pancreas; 1991 Jul; 6(4):419-26. PubMed ID: 1876598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin inhibits pancreatic enzyme secretion at a central vagal site.
    Li Y; Owyang C
    Am J Physiol; 1993 Aug; 265(2 Pt 1):G251-7. PubMed ID: 8103634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of peptide YY on dog and rat pancreatic secretion in vivo and in vitro.
    Bilski J; Hladij M; Jaworek J; Konturek SJ; Varga G
    Int J Pancreatol; 1988 Jul; 3(5):309-21. PubMed ID: 2459272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of peptide YY on cephalic, gastric, and intestinal phases of gastric acid secretion and on the release of gastrointestinal hormones.
    Guo YS; Singh P; Gomez G; Greeley GH; Thompson JC
    Gastroenterology; 1987 May; 92(5 Pt 1):1202-8. PubMed ID: 3557015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxyntomodulin inhibits pancreatic secretion through the nervous system in rats.
    Anini Y; Jarrousse C; Chariot J; Nagain C; Yanaihara N; Sasaki K; Bernad N; Le Nguyen D; Bataille D; Rozé C
    Pancreas; 2000 May; 20(4):348-60. PubMed ID: 10824688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The area postrema lesions alter the inhibitory effects of peripherally infused pancreatic polypeptide on pancreatic secretion.
    Deng X; Wood PG; Sved AF; Whitcomb DC
    Brain Res; 2001 May; 902(1):18-29. PubMed ID: 11376591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracolonic infusion of bile salt stimulates release of peptide YY and inhibits cholecystokinin-stimulated pancreatic exocrine secretion in conscious dogs.
    Izukura M; Hashimoto T; Gomez G; Uchida T; Greeley GH; Thompson JC
    Pancreas; 1991 Jul; 6(4):427-32. PubMed ID: 1876599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide YY antagonizes beta-adrenergic-stimulated release of insulin in dogs.
    Greeley GH; Lluis F; Gomez G; Ishizuka J; Holland B; Thompson JC
    Am J Physiol; 1988 Apr; 254(4 Pt 1):E513-7. PubMed ID: 2895586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central CGRP inhibits pancreatic enzyme secretion by modulation of vagal parasympathetic outflow.
    Li Y; Jiang YC; Owyang C
    Am J Physiol; 1998 Nov; 275(5):G957-63. PubMed ID: 9815024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of peptide-YY from the dog pancreas.
    Zhang T; Sumi S; Thompson JC; Greeley GH
    Endocrinology; 1992 Apr; 130(4):2025-30. PubMed ID: 1547726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.